NASDAQ: ESLA
Estrella Immunopharma Inc Stock Ownership - Who owns Estrella Immunopharma?

Insider buying vs selling

Have Estrella Immunopharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ESLA insiders and whales buy or sell their stock.

ESLA Shareholders

What type of owners hold Estrella Immunopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eureka Therapeutics Inc69.89%25,277,831$21.13MInsider
Jianwei Li6.63%2,399,490$2.01MInsider
Tradeup Acquisition Sponsor LLC3.17%1,145,760$957.86kInsider
Cheng Liu0.82%297,437$248.66kInsider
Jiandong Xu0.73%264,388$221.03kInsider
Hong Zhang0.66%240,481$201.04kInsider
Geode Capital Management LLC0.26%93,418$78.10kInstitution
Ubs Group Ag0.18%65,167$54.48kInstitution
Atw Spac Management LLC0.11%40,000$33.44kInstitution
Blackrock Inc0.07%25,118$21.00kInstitution

1 of 3

ESLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ESLA0.81%82.00%
INKT3.23%96.77%Net BuyingNet Buying
ALGS4.06%95.94%
FGEN35.92%12.82%Net BuyingNet Buying
GDTC0.09%57.45%

Estrella Immunopharma Stock Ownership FAQ

Who owns Estrella Immunopharma?

Estrella Immunopharma (NASDAQ: ESLA) is owned by 0.81% institutional shareholders, 82.00% Estrella Immunopharma insiders, and 17.19% retail investors. Eureka Therapeutics Inc is the largest individual Estrella Immunopharma shareholder, owning 25.28M shares representing 69.89% of the company. Eureka Therapeutics Inc's Estrella Immunopharma shares are currently valued at $20.07M.

If you're new to stock investing, here's how to buy Estrella Immunopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.